Main Page

From - A Hematology Oncology Wiki
Jump to: navigation, search - A Free Hematology/Oncology Reference

Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.

Mobile/tablet version of the main page
Browse our complete index of pages
Quick links to chemotherapy regimens
Acute leukemias
Acute lymphocytic leukemia (ALL) Acute myeloid leukemia (AML) Acute promyelocytic leukemia (APL) Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML) Chronic myelomonocytic leukemia (CMML) Essential thrombocythemia (ET) Hypereosinophilic syndrome (HES)
Mast cell diseases Myelodysplastic syndrome Primary & secondary myelofibrosis Polycythemia vera (PV)
Mature B-, T-, and NK-cell neoplasms
Anaplastic large cell lymphoma (ALCL) Burkitt lymphoma (BL) or Burkitt-like lymphoma Chronic lymphocytic leukemia (CLL/SLL) CNS lymphoma
Cutaneous T-cell lymphoma (CTCL) Diffuse large B-cell lymphoma (DLBCL) Extranodal NK/T-cell lymphoma, nasal type Follicular lymphoma (FL)
Hairy cell leukemia (HCL) HIV-associated lymphoma Hodgkin lymphoma (HL) Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)
Large granular lymphocytic (LGL) leukemia Light-chain (AL) amyloidosis Mantle cell lymphoma (MCL) Marginal zone lymphoma (MZL)
Mediastinal gray-zone lymphoma (MGZL) Multiple myeloma (MM) NK/T-cell lymphoma Peripheral T-cell Lymphoma (PTCL)
Primary mediastinal B-cell lymphoma (PMBL) Transformed lymphoma (TL) Transplant conditioning regimens Waldenström macroglobulinemia (WM/LPL)
Other hematology
Aplastic anemia Autoimmune thrombocytopenic purpura (ITP) Castleman’s disease Coagulopathies
Paroxysmal nocturnal hemoglobinuria (PNH) Venous thromboembolism (VTE)
Solid tumors
Anal cancer Bladder cancer Bone cancer Breast cancer
Central nervous system (CNS) cancer Cervical cancer Colon cancer Esophageal cancer
Gastric cancer Head and neck cancer Hepatobiliary cancer Lung cancer, non-small cell
Lung cancer, small cell Melanoma Mesothelioma Neuroendocrine tumors
Skin, basal & squamous cancer Ovarian cancer Pancreatic cancer Penile cancer
Prostate cancer Rectal cancer Renal cancer Sarcoma
Testicular cancer Thymoma Thyroid cancer Unknown primary
Uterine cancer

Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. By using this site, you are indicating that you have read and agree with the terms set forth in the disclaimer. Priorities of this project include:

  1. Creating a database of chemotherapy agents and other medications.
  2. Creating an index of diseases.
  3. Creating a collection of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
  4. Sample order sets and examples of supportive medications used with treatment regimens
  5. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

  1. Creating summaries of pivotal clinical trials
  2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
  3. Checklists for common clinical scenarios/diseases
  4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
  5. List of ICD-9 codes
  6. Being a source of reference documents
  7. Pathology references, including histology images and information about immunohistochemistry and CD markers.

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.

If you would like to contribute, please create an account in the upper right corner, and send a message to so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.